Victomed Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.90 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -2.97%
- Profit Growth -3.36%
- Ebitda -18.29%
- Net Worth 1.10%
- Total Assets 0.95%
About Victomed Pharmaceuticals
Victomed Pharmaceuticals Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 July 2017 (Seven years and seven months 0 days old ). Its registered office is in Theni, Tamil Nadu, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Raja Natchiappan, Jhansiranik, Ramya, and Seven other members serve as directors at the Company.
Company Details
-
Location
Theni, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TN2017PTC117401
-
Company No.
117401
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jul 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Victomed Pharmaceuticals?
Board Members (10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raja Natchiappan
|
Director | 05-Jul-2017 | Current |
|
Jhansiranik
|
Director | 05-Jul-2017 | Current |
|
Ramya
|
Director | 05-Jul-2017 | Current |
|
Sundaravadivel Subramanian
|
Director | 05-Jul-2017 | Current |
|
Karthikeyan Govindaswamy
|
Director | 05-Jul-2017 | Current |
|
Jabar Sithick
|
Director | 05-Jul-2017 | Current |
Financial Performance of Victomed Pharmaceuticals.
Victomed Pharmaceuticals Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.97% decrease. The company also saw a slight decrease in profitability, with a 3.36% decrease in profit. The company's net worth moved up by a moderate rise of 1.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Victomed Pharmaceuticals?
Unlock access to Victomed Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Confervo Formulations Private LimitedSenthilkumar Murugesan is a mutual person
-
Behandler Pharmaceuticals Private Limited
Senthilkumar Murugesan is a mutual person
-
Pharmacien Life Sciences Private Limited
Senthilkumar Murugesan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Victomed Pharmaceuticals?
Unlock and access historical data on people associated with Victomed Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Victomed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Victomed Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
